Pre-infection antiviral innate immunity contributes to sex differences in SARS-CoV-2 infection. Author Natalie Sauerwald, Zijun Zhang, Irene Ramos, Venugopalan Nair, Alessandra Soares-Schanoski, Yongchao Ge, Weiguang Mao, Hala Alshammary, Ana Gonzalez-Reiche, Adriana van de Guchte, Carl Goforth, Rhonda Lizewski, Stephen Lizewski, Mary Amper, Mital Vasoya, Nitish Seenarine, Kristy Guevara, Nada Marjanovic, Clare Miller, German Nudelman, Megan Schilling, Rachel Sealfon, Michael Termini, Sindhu Vangeti, Dawn Weir, Elena Zaslavsky, Maria Chikina, Ying Wu, Harm van Bakel, Andrew Letizia, Stuart Sealfon, Olga Troyanskaya Publication Year 2022 Type Journal Article Abstract Male sex is a major risk factor for SARS-CoV-2 infection severity. To understand the basis for this sex difference, we studied SARS-CoV-2 infection in a young adult cohort of United States Marine recruits. Among 2,641 male and 244 female unvaccinated and seronegative recruits studied longitudinally, SARS-CoV-2 infections occurred in 1,033 males and 137 females. We identified sex differences in symptoms, viral load, blood transcriptome, RNA splicing, and proteomic signatures. Females had higher pre-infection expression of antiviral interferon-stimulated gene (ISG) programs. Causal mediation analysis implicated ISG differences in number of symptoms, levels of ISGs, and differential splicing of CD45 lymphocyte phosphatase during infection. Our results indicate that the antiviral innate immunity set point causally contributes to sex differences in response to SARS-CoV-2 infection. A record of this paper's transparent peer review process is included in the supplemental information. Keywords Humans, Female, Male, Proteomics, Immunity, Innate, Interferons, Sex Characteristics, Young Adult, COVID-19, SARS-CoV-2 Journal Cell Syst Volume 13 Issue 11 Pages 924-931.e4 Date Published 2022 Nov 16 ISSN Number 2405-4720 DOI 10.1016/j.cels.2022.10.005 Alternate Journal Cell Syst PMCID PMC9623453 PMID 36323307 PubMedPubMed CentralGoogle ScholarBibTeXEndNote X3 XML